Association of LEPR and ANKK1 Gene Polymorphisms with Weight Gain in Epilepsy Patients Receiving Valproic Acid

BACKGROUND: Weight gain is the most frequent adverse effect of valproic acid (VPA) treatment, resulting in poor compliance and many endocrine disturbances. Similarities in the weight change of monozygotic twins receiving VPA strongly suggests that genetic factors are involved in this effect. However...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Hongliang, Wang, Xueding, Zhou, Yafang, Ni, Guanzhong, Su, Qibiao, Chen, Ziyi, Chen, Zhuojia, Li, Jiali, Chen, Xinmeng, Hou, Xiangyu, Xie, Wen, Xin, Shuang, Zhou, Liemin, Huang, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4540110/
https://www.ncbi.nlm.nih.gov/pubmed/25740917
http://dx.doi.org/10.1093/ijnp/pyv021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4540110/
https://www.ncbi.nlm.nih.gov/pubmed/25740917
http://dx.doi.org/10.1093/ijnp/pyv021

Ejemplares similares